Skip to main content
. 2021 Mar 11;11:5679. doi: 10.1038/s41598-021-83646-7

Figure 1.

Figure 1

(a) Ages of ALK-positive (ALK +) patients compared to ALK-negative (ALK-) patients. Patients; (b) tumour size between wild-type EGFR (EGFR-) and mutated EGFR (EGFR +); (c) receiver operating characteristic curves of age for predicting ALK positivity; (d) receiver operating characteristic curves of the tumour maximum diameter for predicting EGFR mutations.